Answers are grounded in this paper and cite their sources.
Natural products of marine origin have become an attractive area in the search of new anti-cancer agents because of their distinct chemical novelty and the presence of strong bioactive substances. This study was intended to examine pharmacognostic potential of a few marine-derived compounds on cancer cell proliferation in animal experimental models. Marine sponges and algae were extracted crudely and screened phytochemically, and then in vivo assayed in tumor-induced mice models. The information was obtained by the measurement of tumor volume, analysis of survival rates, and histopathological tests. It was found that alkaloids isolated in marine sponges showed a significant decrease of the tumor volume (mean = 45.2 mm 3, SD = 4.8) compared to control (mean = 92.6 mm 3, SD = 6.2), whereas terpenoids isolated in algae increased survival rates and caused strong apoptosis in cancerous tissues. In general, the results indicate that bioactive compounds of marine origin have strong anti-cancer activity, which underlines their significance as new pharmacognostic sources of cancer treatment. The paper highlights the need of marine pharmacognosy in the broadening of natural product-based drug discovery and suggests additional research to achieve efficacy, safety, and mechanistic insights.
No takes yet. Share an insight, caveat, or question.
Thakur et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: